meglumine has been researched along with Central Nervous System Diseases in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (11.11) | 18.7374 |
1990's | 6 (66.67) | 18.2507 |
2000's | 2 (22.22) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Essig, M | 1 |
Anzalone, N; Bowen, BC; Essig, M; Gustafsson, L; Knopp, MV; Kremer, S; Kuhn, MJ; Maldjian, JA; Maravilla, KR; Runge, VM; Schmalfuss, IM; Wippold, FJ; Wolansky, LJ | 1 |
Boyer, L; Bruneton, JN; Chanalet, S; Laffont, J; Masson, B | 1 |
Kuijpers, TJ; Oudkerk, M; Sijens, PE; Van Beek, EJ | 1 |
Enzmann, DR; Haros, SP; Mehta, RC; Pike, GB | 1 |
Beck, W; Haustein, J; Kaiser, W; Laniado, M; Louton, T; Niendorf, HP; Planitzer, J; Reiser, M; Schöffel, M; Schörner, W | 1 |
Gordon, P; Hugo, F; Lundby, B | 1 |
Kirchin, MA; Pirovano, GP; Spinazzi, A | 1 |
Hein, O; Jensen, TS | 1 |
2 review(s) available for meglumine and Central Nervous System Diseases
Article | Year |
---|---|
Clinical experience with MultiHance in CNS imaging.
Topics: Central Nervous System Diseases; Contrast Media; Gadolinium; Humans; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Randomized Controlled Trials as Topic; Sensitivity and Specificity | 2003 |
Gadobenate dimeglumine (Gd-BOPTA). An overview.
Topics: Animals; Central Nervous System Diseases; Contrast Media; Gadolinium; Heart Diseases; Humans; Liver Diseases; Magnetic Resonance Angiography; Meglumine; Organometallic Compounds | 1998 |
5 trial(s) available for meglumine and Central Nervous System Diseases
Article | Year |
---|---|
Contrast enhancement of central nervous system lesions: multicenter intraindividual crossover comparative study of two MR contrast agents.
Topics: Central Nervous System Diseases; Contrast Media; Cross-Over Studies; Double-Blind Method; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Prospective Studies; Statistics, Nonparametric | 2006 |
[Comparative studies of the tolerability of gadodiamide, dimeglumine gadopentetate and meglumine gadoterate in MRI tests of the central nervous system].
Topics: Adult; Central Nervous System Diseases; Contrast Media; Double-Blind Method; Drug Combinations; Drug Hypersensitivity; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Risk Factors | 1995 |
Safety and efficacy of dotarem (Gd-DOTA) versus magnevist (Gd-DTPA) in magnetic resonance imaging of the central nervous system.
Topics: Adult; Aged; Central Nervous System; Central Nervous System Diseases; Chi-Square Distribution; Contrast Media; Double-Blind Method; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid | 1995 |
Triple-dose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients.
Topics: Adult; Central Nervous System Diseases; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pentetic Acid | 1993 |
MRI in children given gadodiamide injection: safety and efficacy in CNS and body indications.
Topics: Adolescent; Central Nervous System Diseases; Child; Child, Preschool; Clinical Trials, Phase III as Topic; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Humans; Infant; Infant, Newborn; Magnetic Resonance Imaging; Meglumine; Multicenter Studies as Topic; Organometallic Compounds; Pentetic Acid; Randomized Controlled Trials as Topic; Safety | 1996 |
2 other study(ies) available for meglumine and Central Nervous System Diseases
Article | Year |
---|---|
Central nervous system tumor, infection, and infarction: detection with gadolinium-enhanced magnetization transfer MR imaging.
Topics: Adult; Aged; Brain; Brain Neoplasms; Central Nervous System Diseases; Cerebral Infarction; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Prospective Studies | 1995 |
Intraspinal arachnoiditis and hydrocephalus after lumbar myelography using methylglucamine iocarmate.
Topics: Adult; Arachnoiditis; Central Nervous System Diseases; Cerebral Ventriculography; Cerebrospinal Fluid Shunts; Contrast Media; Female; Humans; Hydrocephalus; Laminectomy; Meglumine; Myelography; Sorbitol; Spinal Cord Diseases | 1978 |